Literature DB >> 2684108

Reduced protein kinase C immunoreactivity and altered protein phosphorylation in Alzheimer's disease fibroblasts.

T Van Huynh1, G Cole, R Katzman, K P Huang, T Saitoh.   

Abstract

Abnormal protein kinase C levels and protein kinase C-dependent phosphorylation are biochemical alterations in brain tissue obtained from patients with Alzheimer's disease. Because many biochemical and biophysical abnormalities are found in peripheral tissues of patients with Alzheimer's disease, we studied protein kinase C levels and the in vitro phosphorylation of proteins under protein kinase C-activating conditions in fibroblasts derived from patients with Alzheimer's disease. The concentration of protein kinase C-like immunoreactivity was reduced in Alzheimer's disease samples, although the protein kinase C activity determined by the phosphorylation of exogenous histone was not. The degree of in vitro phosphorylation of an Mr 79,000 protein in the presence of protein kinase C activators was less in Alzheimer's disease than in control fibroblast cytosol, and a reduction was more prominent in cases of familial Alzheimer's disease than in sporadic Alzheimer's disease. Therefore, the aberrant phosphorylation mediated by protein kinase C is found not only in the brain but also in fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684108     DOI: 10.1001/archneur.1989.00520470049026

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  12 in total

Review 1.  Age-related alteration of PKC, a key enzyme in memory processes: physiological and pathological examples.

Authors:  A Pascale; S Govoni; F Battaini
Journal:  Mol Neurobiol       Date:  1998-02       Impact factor: 5.590

2.  Evaluation of systemic administration of Boswellia papyrifera extracts on spatial memory retention in male rats.

Authors:  Ali Mahmoudi; Ali Hosseini-Sharifabad; Hamid R Monsef-Esfahani; Ali R Yazdinejad; Mahnaz Khanavi; Ali Roghani; Cordian Beyer; Mohammad Sharifzadeh
Journal:  J Nat Med       Date:  2011-04-11       Impact factor: 2.343

Review 3.  Changes in the ageing brain in health and disease.

Authors:  B H Anderton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-12-29       Impact factor: 6.237

4.  Lead-induced accumulation of beta-amyloid in the choroid plexus: role of low density lipoprotein receptor protein-1 and protein kinase C.

Authors:  Mamta Behl; Yanshu Zhang; Yunzhou Shi; Jixin Cheng; Yansheng Du; Wei Zheng
Journal:  Neurotoxicology       Date:  2010-05-19       Impact factor: 4.294

5.  Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation.

Authors:  J D Buxbaum; S E Gandy; P Cicchetti; M E Ehrlich; A J Czernik; R P Fracasso; T V Ramabhadran; A J Unterbeck; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

6.  Alzheimer's-specific effects of soluble beta-amyloid on protein kinase C-alpha and -gamma degradation in human fibroblasts.

Authors:  A Favit; M Grimaldi; T J Nelson; D L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

7.  Bradykinin-induced amyloid precursor protein secretion: a protein kinase C-independent mechanism that is not altered in fibroblasts from patients with sporadic Alzheimer's disease.

Authors:  M Racchi; P Ianna; G Binetti; M Trabucchi; S Govoni
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

8.  An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin.

Authors:  Tapan K Khan; Daniel L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-18       Impact factor: 11.205

9.  Inhibition of protein phosphatase 1 stimulates secretion of Alzheimer amyloid precursor protein.

Authors:  E F da Cruz e Silva; O A da Cruz e Silva; C T Zaia; P Greengard
Journal:  Mol Med       Date:  1995-07       Impact factor: 6.354

10.  Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait-linked phenotype.

Authors:  T Yamatsuji; T Okamoto; S Takeda; Y Murayama; N Tanaka; I Nishimoto
Journal:  EMBO J       Date:  1996-02-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.